In early April, the Health Ministry announced the beginning of a new era for Israel’s cannabis reform, with the message being, “Enough with bureaucracy.”
Shortage of doctors and opting for private markets
Just when it seemed that the long-awaited solution had been found and after October 7, there would be maximum understanding for this population, as of today, the appropriate answer has not yet been found – neither for post-traumatic sufferers nor for the majority of people suffering from chronic pain.
Cannabis brought me back to life
“Why should a person with post-traumatic stress disorder have to experiment with harsh psychiatric medications just to get permission to consume medical cannabis that can benefit them,” wonders Noy (pseudonym), a medical cannabis patient following post-trauma from an incident of domestic violence she experienced. For her and her friends, the guidelines have not changed. “We were left behind in the reform; it doesn’t speak to us. The post-traumatic stress disorder broke out for me after 20 years. I was officially diagnosed only in the last two years, and I had to take drugs that hurt me mentally. Drugs that didn’t suit me and affected everything in my life. Nothing helped me like cannabis; it brought me back to life. Why do patients have to suffer so much? I reduced the use of the plant significantly to a few grams, and that’s only thanks to the cannabis. I also tried to contact the doctors on the list of the Health Ministry.”
Just before the introduction of the reform, Noy paid a private psychiatrist NIS 1,200 for the license and hundreds of shekels a week for the purchase of cannabis, an amount that adds up to thousands of shekels a month.
Health Ministry responds
The Health Ministry said in response, “The reform in the field of cannabis that came into effect on April 1 is an important and significant step in easing the life of medical cannabis patients and improving the quality of their medical care. The introduction of the reform did not change the way of obtaining prescriptions or licenses for cannabis, which are only given under public medicine. At the same time, after the reform comes into effect, it will be possible to receive a recommendation from a private doctor to be examined by the relevant authorities in the HMOs. Regarding the claim of post-trauma, as part of the implementation of the recommendations of the Boaz Lev Committee, the professional committee that examined the issue, and in light of the complexity of the transition from licenses to prescriptions, the full transition to prescriptions will be done in two stages After the full implementation of the current phase, the completion of the procedure will be examined in the labeling rule.”